Development of a Risk Classifier to Predict Tumor Recurrence and Lenvatinib Benefits in Hepatocellular Carcinoma After Liver Transplantation
- Resource Type
- Article
- Source
- In
Transplantation Proceedings January-February 2023 55(1):153-163 - Subject
- Language
- ISSN
- 0041-1345